HBIOHarvard Bioscience, Inc.
5.720USD+2.32%Mkt Cap: 25.46M USDP/E: Last update: 2026-05-26

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offer…

Indicators:|

Key Statistics

Company
Market Cap25.46M USD
Enterprise Value53.80M USD
Revenue (TTM)85.53M USD
Gross Profit49.91M USD
Net Income (TTM)-56.70M USD
Revenue/Share19.20 USD
Last Price5.720 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees316
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS4169061052
Valuation
P/E (Trailing)
P/E (Forward)12.55
PEG1.31
EV/EBITDA6.88
EV/Revenue0.63
P/S0.29
P/B2.46
EPS (TTM)-2.15
EPS (Forward)0.44
52W Range
2.80044% of range9.500
52W High9.500 USD
52W Low2.800 USD
Profitability
Gross Margin57.67%
Oper. Margin-5.66%
EBITDA Margin9.14%
Profit Margin-65.51%
ROE-412.84%
ROA-70.81%
Growth
Revenue Growth-4.70%
Earnings Growth
Cash Flow & Leverage
Operating CF6.73M USD
CapEx (TTM)1.86M USD
FCF Margin11.27%
FCF Yield37.86%
Net Debt29.11M USD
Net Debt/EBITDA3.72
Balance Sheet
Debt/Equity3.22
Current Ratio1.99
Quick Ratio0.91
Book Value/Sh2.246 USD
Cash/Share1.587 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:10
Split DateMar 16, 2026
Analyst Consensus
Rating2.5 (Hold)
Target (Mean)6.000 USD
Target Range6.000 USD6.000 USD
# Analysts1
Ownership
Shares Out.4.51M
Float3.50M
Insiders7.65%
Institutions45.91%
Short Interest
Short Ratio2.5d
Short % Float3.85%
Short % Out.3.79%
Shares Short170.73K
Short (prev mo.)84.76K
Technical
SMA 505.672 (+0.8%)
SMA 2005.601 (+2.1%)
Beta
S&P 52W Chg28.31%
Avg Vol (30d)41.30K
Avg Vol (10d)30.99K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)